BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8790152)

  • 21. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development.
    Basch RS; Zhang XM; Dolzhanskiy A; Karpatkin S
    Br J Haematol; 1999 Jun; 105(4):1044-54. PubMed ID: 10554819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group.
    Takeshita A; Shinjo K; Higuchi M; Miyawaki S; Takemoto Y; Kishimoto Y; Saito K; Takuchi H; Kuriyama K; Kimura Y; Asou N; Takahashi M; Hotta T; Kanamaru A; Ueda R; Ohno R
    Br J Haematol; 2000 Jan; 108(1):55-63. PubMed ID: 10651724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
    Sawai N; Koike K; Ito S; Kurokawa Y; Mwamtemi HH; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Ogami K; Komiyama A
    Stem Cells; 1999; 17(1):45-53. PubMed ID: 10215401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hierarchical structure of human megakaryocyte progenitor cells.
    Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
    Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietin.
    Motoji T; Hoshino S; Ueda M; Takanashi M; Masuda M; Nakayama K; Oshimi K; Mizoguchi H
    Br J Haematol; 1990 May; 75(1):60-7. PubMed ID: 2375925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
    Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
    Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
    FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay.
    Motoji T; Watanabe M; Uzumaki H; Kusaka M; Fukamachi H; Shimosaka A; Oshimi K; Mizoguchi H
    Br J Haematol; 1991 Jan; 77(1):54-9. PubMed ID: 1705433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines.
    Shinohara A; Shimizu E; Takada M; Sone S
    Oncology; 1996; 53(5):426-34. PubMed ID: 8784480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
    Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
    Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial 9q deletion in T-lymphoid/myeloid biphenotypic leukaemia.
    Akashi K; Shibuya T; Harada M; Oogami A; Teshima T; Takamatsu Y; Kikuchi M; Niho Y
    Br J Haematol; 1992 Feb; 80(2):172-7. PubMed ID: 1550772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination.
    Karnik MP; Nair CN; Zingde SM; Gothoskar BP; Zachariah L; Barbhaya S; Advani SH
    Indian J Med Res; 1994 Dec; 100():272-6. PubMed ID: 7829166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
    Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.